Clinical Trial Update: Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease [NA]

View source ↗

Summary

Clinical trial evaluating the acceptability of the Somnomat Casa for treating Parkinson disease and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Parkinson Disease | NA | Status: RECRUITING